Reinforcement of the Triple D score with simple addition of the intrarenal location for the prediction of the stone-free rate after shockwave lithotripsy for renal stones 10-20 mm in diameter.


Journal

International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 27 10 2018
accepted: 24 12 2018
pubmed: 4 1 2019
medline: 8 6 2019
entrez: 4 1 2019
Statut: ppublish

Résumé

We investigated the clinical efficacy of the Triple D score (TrD-S) on stone-free rate (SFR) prediction following shockwave lithotripsy (SWL) for renal stones 10-20 mm in diameter and modified the scoring system to improve outcome prediction. We retrospectively examined clinical data from the medical records of 226 consecutive patients who underwent SWL for 10-20 mm kidney stones. The TrD-S was calculated according to the cutoffs of < 150 mm The residual group (n = 102) had significantly older age, larger stones, higher stone density, higher lower-pole stone incidence, and lower TrD-S than the stone-free group (n = 124). In the multivariate analysis, age, TrD-S, and non-lower-pole stones independently predicted the SFR. The TrD-Ss of 0, 1, 2, and 3 points showed SFRs of 40.0%, 51.9%, 73.0%, and 100.0%, respectively. The Quadruple D scores of 0, 1, 2, 3, and 4 points showed SFRs of 0.0%, 37.9%, 54.5%, 84.4%, and 100.0%, respectively, with better prediction accuracy than the TrD-S (p = 0.01). The TrD-S is successfully validated for use in Japanese patients with 10-20-mm renal stones. Simple addition of the stone location to the TrD-S could reinforce SFR prediction after SWL.

Identifiants

pubmed: 30604235
doi: 10.1007/s11255-018-02066-1
pii: 10.1007/s11255-018-02066-1
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

239-245

Références

Circ J. 2002 Nov;66(11):987-92
pubmed: 12419927
J Urol. 2003 May;169(5):1679-81
pubmed: 12686807
Scand J Urol Nephrol. 2003;37(5):413-8
pubmed: 14594691
Scand J Urol Nephrol. 2004;38(2):161-7
pubmed: 15204407
J Urol. 2004 Dec;172(6 Pt 1):2271-4
pubmed: 15538247
J Urol. 2005 Jan;173(1):127-30
pubmed: 15592053
Urology. 2005 Jan;65(1):33-6
pubmed: 15667858
BJU Int. 2005 Nov;96(7):1145
pubmed: 16225548
Urology. 2005 Nov;66(5):941-4
pubmed: 16286099
J Urol. 2006 Oct;176(4 Pt 1):1453-6; discussion 1456-7
pubmed: 16952658
Aging Male. 2006 Sep;9(3):171-4
pubmed: 17020872
Eur Urol. 2007 Jun;51(6):1688-93; discussion 1693-4
pubmed: 17161522
Scand J Urol Nephrol. 2007;41(4):316-23
pubmed: 17763224
Urology. 2008 Oct;72(4):765-9
pubmed: 18674803
J Urol. 2009 Mar;181(3):1151-7
pubmed: 19152949
J Endourol. 2009 Jun;23(6):891-7
pubmed: 19441881
J Urol. 2011 Aug;186(2):556-62
pubmed: 21684557
Can J Urol. 2012 Dec;19(6):6554-9
pubmed: 23228291
J Endourol. 2015 Feb;29(2):226-30
pubmed: 25046472
Urolithiasis. 2015 Oct;43(5):419-26
pubmed: 25981235
Eur Urol. 2016 Mar;69(3):475-82
pubmed: 26344917
PLoS One. 2016 Feb 18;11(2):e0149333
pubmed: 26890006
J Urol. 2016 Oct;196(4):1161-9
pubmed: 27238615
J Endourol. 2016 Sep;30(9):1009-16
pubmed: 27392789
J Endourol. 2017 Feb;31(2):169-173
pubmed: 27889982
J Urol. 2018 May;199(5):1267-1271
pubmed: 29221932
BMC Urol. 2018 Apr 10;18(1):25
pubmed: 29636048
J Urol. 1988 May;139(5):1124-7
pubmed: 3361657

Auteurs

Osamu Ichiyanagi (O)

Department of Urology, Yamagata University Faculty of Medicine, 2-2-2 Iida-nishi, Yamagata, 998-9585, Japan. oichiyan@ab.cyberhome.ne.jp.
Department of Urology, Yamagata Prefectural Kahoku Hospital, 111 Aza-Gassando, Yachi, Kahoku, 999-3511, Japan. oichiyan@ab.cyberhome.ne.jp.

Hiroki Fukuhara (H)

Department of Urology, Yamagata University Faculty of Medicine, 2-2-2 Iida-nishi, Yamagata, 998-9585, Japan.
Department of Urology, Nihonkai General Hospital, 30 Akiho-cho, Sakata, 998-8501, Japan.

Masayuki Kurokawa (M)

Department of Urology, Nihonkai General Hospital, 30 Akiho-cho, Sakata, 998-8501, Japan.

Takuji Izumi (T)

Department of Urology, South Miyagi Medical Center, 38-1 Aza-nishi, Ogawara, Miyagi, 989-1253, Japan.

Hitoshi Suzuki (H)

Department of Urology, Yamagata City Hospital Saiseikan, 1-3-26 Nanoka-mahi, Yamagata, 990-8533, Japan.

Sei Naito (S)

Department of Urology, Yamagata University Faculty of Medicine, 2-2-2 Iida-nishi, Yamagata, 998-9585, Japan.

Hayato Nishida (H)

Department of Urology, Yamagata University Faculty of Medicine, 2-2-2 Iida-nishi, Yamagata, 998-9585, Japan.

Tomoyuki Kato (T)

Department of Urology, Yamagata University Faculty of Medicine, 2-2-2 Iida-nishi, Yamagata, 998-9585, Japan.

Norihiko Tsuchiya (N)

Department of Urology, Yamagata University Faculty of Medicine, 2-2-2 Iida-nishi, Yamagata, 998-9585, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH